STOCK TITAN

American Well (AMWL) Files Rule 144 Notice for 4,781 RSU Shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

American Well Corporation (AMWL) Form 144 notifies the market of a proposed sale under Rule 144 of 4,781 Class A common shares with an aggregate market value of $32,422.35, expected to occur on 09/02/2025 on the NYSE. The shares were acquired through the vesting of restricted stock units on 09/01/2025. The filing lists total outstanding Class A shares of 14,162,309 and shows prior sales by the same person on 06/02/2025 (4,782 shares, $31,628.15) and 07/01/2025 (4,958 shares, $42,773.16).

Positive

  • Clear disclosure of the proposed sale under Rule 144, including dates, amounts, and broker information
  • Securities originated from RSU vesting, indicating a compensation-related transaction rather than corporate fundraising
  • Seller attests there is no undisclosed material adverse information, aligning with compliance expectations

Negative

  • Insider sales over recent months (06/02/2025 and 07/01/2025) may attract investor attention despite small sizes
  • Aggregate proceeds are small but repeated dispositions could be viewed negatively by some market participants

Insights

TL;DR: Small insider sale from RSU vesting; not materially dilutive given the outstanding share count.

The proposed sale of 4,781 shares valued at $32,422.35 represents a de minimis fraction of the reported 14,162,309 outstanding Class A shares (approximately 0.034%). The shares originate from RSU vesting, indicating compensation-related disposition rather than a cash-raising event by the company. Recent near-monthly sales by the same person are documented, but aggregate proceeds remain modest. For investors, this filing signals routine insider liquidity rather than a materially adverse corporate development.

TL;DR: Filing shows compliance with Rule 144 and required insider attestation; pattern of small sales is disclosed.

The Form 144 includes the seller's representation regarding absence of undisclosed material adverse information and lists the transaction as RSU vesting followed by planned sale. The notice aligns with Rule 144 disclosure obligations and provides dates and historical sales. While recurring small disposals by an insider may attract interest, the filing demonstrates transparent compliance with securities law and company reporting practices.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the AMWL Form 144 filed on 09/02/2025 disclose?

The filing notifies a proposed sale of 4,781 Class A shares valued at $32,422.35, acquired via RSU vesting, with an expected sale date of 09/02/2025 on the NYSE.

Who is selling the shares in the AMWL Form 144?

The filing identifies the seller as the person for whose account the securities are to be sold; past sales listed name Phyllis Gotlib for earlier transactions in June and July 2025.

How many Class A shares does AMWL report outstanding in this filing?

The filing shows 14,162,309 Class A shares outstanding.

Were the shares sold acquired by purchase or other means?

The shares were acquired through the vesting of restricted stock unit grants on 09/01/2025.

Does the Form 144 indicate any undisclosed adverse information about AMWL?

By signing, the person represents they do not know any material adverse information not publicly disclosed; no other adverse information is provided in the filing.
American Well Corp

NYSE:AMWL

View AMWL Stock Overview

AMWL Rankings

AMWL Latest News

AMWL Latest SEC Filings

AMWL Stock Data

95.34M
13.53M
Health Information Services
Services-business Services, Nec
Link
United States
Boston